menu
    • menu

    Company profile for Prokarium

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Prokarium is a clinical-stage biopharmaceutical company focused on developing microbial cancer immunotherapies. Using the company’s leading-edge technology platform, Prokarium’s mission is to use its expertise in engineering biology and immunology to improve the lives of patients with solid tumours, with its lead oncology program expected to enter the clinic in 2022. The Company is also leveraging its platform, in conjunct...
    Prokarium is a clinical-stage biopharmaceutical company focused on developing microbial cancer immunotherapies. Using the company’s leading-edge technology platform, Prokarium’s mission is to use its expertise in engineering biology and immunology to improve the lives of patients with solid tumours, with its lead oncology program expected to enter the clinic in 2022. The Company is also leveraging its platform, in conjunction with the Wellcome Trust, for the Phase 1 and Phase 2 clinical evaluation of a combination vaccine against typhoid and paratyphoid. Prokarium is headquartered in London, UK.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Prokariumunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    London Bioscience Innovation Centre, 2 Royal College St, NW1 0NH, London,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.prokarium.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/prokarium/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prokarium Appoints Ibs Mahmood As Chief Executive Officer
    Prokarium Appoints Ibs Mahmood As Chief Executive Officer

    11 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111792832/en/Prokarium-Appoints-Ibs-Mahmood-as-Chief-Executive-Officer

    BUSINESSWIRE
    11 Nov 2025
    Share Share
    Prokarium Expands IP Portfolio with Bladder Cancer Patents
    Prokarium Expands IP Portfolio with Bladder Cancer Patents

    01 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241101383023/en

    BUSINESSWIRE
    01 Nov 2024
    Share Share
    Prokarium Achieves Milestone with First Dosing in Invasive Bladder Cancer Trial
    Prokarium Achieves Milestone with First Dosing in Invasive Bladder Cancer Trial

    07 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240207504370/en

    BUSINESSWIRE
    07 Feb 2024
    Share Share
    Prokarium Achieves Milestone with FDA's IND Approval for Bladder Cancer Program
    Prokarium Achieves Milestone with FDA's IND Approval for Bladder Cancer Program

    02 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231102543739/en

    BUSINESSWIRE
    02 Nov 2023
    Share Share
    Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic
    Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic

    09 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230209005006/en/Prokarium-Announces-30-Million-Financing-to-Deliver-Lead-Program-into-Clinic-and-Build-Novel-Therapeutic-Platform

    BUSINESSWIRE
    09 Feb 2023
    Share Share
    Prokarium raises $30M, pushes new bacteria immunotherapy for bladder cancer
    Prokarium raises $30M, pushes new bacteria immunotherapy for bladder cancer

    09 Feb 2023

    // Lei Lei Wu ENDPTS

    https://endpts.com/prokarium-raises-30m-pushes-new-bacteria-immunotherapy-for-bladder-cancer-to-clinic/

    Lei Lei Wu ENDPTS
    09 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search